Nathan Ford
About
Nathan Ford is a scholar working on Infectious Diseases, Epidemiology and Virology.
According to data from OpenAlex, Nathan Ford has authored 306 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Infectious Diseases, 115 papers in Epidemiology and 64 papers in Virology. Recurrent topics in Nathan Ford's work include HIV/AIDS Research and Interventions (187 papers), HIV/AIDS drug development and treatment (75 papers) and HIV Research and Treatment (64 papers). Nathan Ford is often cited by papers focused on HIV/AIDS Research and Interventions (187 papers), HIV/AIDS drug development and treatment (75 papers) and HIV Research and Treatment (64 papers). Nathan Ford collaborates with scholars based in South Africa, Switzerland and United Kingdom. Nathan Ford's co-authors include Edward J. Mills, Katharina Kranzer, Darshini Govindasamy, Marco Vitória, Meg Doherty, Helen Schneider, Mike Callaghan, Alexandra Calmy, Jean B. Nachega and Piero Olliaro and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.
In The Last Decade
Nathan Ford
298 papers receiving 14.8k citations
Hit Papers
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Nathan Ford | 9.7k | 5.7k | 3.6k | 3.4k | 2.3k | 306 | 15.3k | |
| Sten H. Vermund | 9.7k 1.0× | 9.1k 1.6× | 4.2k 1.2× | 2.9k 0.9× | 1.4k 0.6× | 587 | 18.2k | |
| Nelson K. Sewankambo | 9.3k 0.9× | 5.7k 1.0× | 6.3k 1.8× | 4.0k 1.2× | 1.9k 0.8× | 366 | 18.9k | |
| Anthony Harries | 10.8k 1.1× | 8.1k 1.4× | 2.1k 0.6× | 1.2k 0.4× | 1.9k 0.8× | 523 | 15.9k | |
| Jean B. Nachega | 9.1k 0.9× | 3.9k 0.7× | 2.9k 0.8× | 2.6k 0.8× | 848 0.4× | 193 | 11.6k | |
| Matthew P. Fox | 7.9k 0.8× | 4.7k 0.8× | 2.6k 0.7× | 3.0k 0.9× | 2.1k 0.9× | 343 | 14.2k | |
| Rochelle P. Walensky | 8.9k 0.9× | 5.3k 0.9× | 2.2k 0.6× | 3.1k 0.9× | 661 0.3× | 302 | 13.2k | |
| Jonathan Mermin | 11.1k 1.1× | 7.7k 1.4× | 4.1k 1.1× | 3.0k 0.9× | 1.1k 0.5× | 203 | 15.4k | |
| Marie‐Louise Newell | 13.9k 1.4× | 8.2k 1.5× | 6.2k 1.7× | 4.7k 1.4× | 2.8k 1.2× | 427 | 19.8k | |
| David Serwadda | 10.6k 1.1× | 6.8k 1.2× | 8.2k 2.3× | 4.7k 1.4× | 1.7k 0.7× | 302 | 22.0k | |
| Kevin M. De Cock | 10.1k 1.0× | 7.3k 1.3× | 2.2k 0.6× | 2.5k 0.7× | 672 0.3× | 250 | 13.5k |
Countries citing papers authored by Nathan Ford
Since
Specialization
Citations
This map shows the geographic impact of Nathan Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Ford more than expected).
Fields of papers citing papers by Nathan Ford
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nathan Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Ford. The network helps show where Nathan Ford may publish in the future.
Co-authorship network of co-authors of Nathan Ford
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Ford. A scholar is included among the top collaborators of Nathan Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Ford. Nathan Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Amstutz, Alain, Sydney Rosen, Alana T. Brennan, et al.. (2025). Effect of same-day HIV treatment initiation (SDI) on 1-year outcomes in low- and middle-income countries: systematic review and meta-analysis of randomised trials. BMJ Global Health. 10(12). e021759–e021759.
2.
Kennedy, Caitlin E., Ping Teresa Yeh, Michelle Rodolph, et al.. (2025). HIV post‐exposure prophylaxis in community settings and by lay health workers or through task sharing: a systematic review of effectiveness, case studies, values and preferences, and costs. Journal of the International AIDS Society. 28(5). e26448–e26448.
3.
May, Carl, Nathan Ford, Gavin I. Welsh, & Moin A. Saleem. (2025). Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review. PLoS ONE. 20(2). e0312232–e0312232.
4.
Wamuti, Beatrice, Muhammad S. Jamil, Nandi Siegfried, et al.. (2024). Understanding effective post‐test linkage strategies for HIV prevention and care: a scoping review. Journal of the International AIDS Society. 27(4). e26229–e26229.
5.
Easterbrook, Philippa, Nathan Ford, William L. Irving, et al.. (2024). Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 79(6). 1437–1446.
6.
McMullan, Brendan, Hannah Yejin Kim, Ana Alastruey‐Izquierdo, et al.. (2024). Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list. Medical Mycology. 62(6).
7.
Wilson, Alison, et al.. (2024). Otitis media, Bell’s palsy, and osteomyelitis…Oh My!. The American Journal of the Medical Sciences. 367. S450–S450.
8.
Burke, Rachael M., Marriott Nliwasa, Ankur Gupta‐Wright, et al.. (2023). Interventions to reduce deaths in people living with HIV admitted to hospital in low- and middle-income countries: A systematic review. SHILAP Revista de lepidopterología. 3(2). e0001557–e0001557.
9.
Fonner, Virginia A., Niklas Luhmann, Nandi Siegfried, et al.. (2023). Use of indirect evidence from HIV self-testing to inform the WHO hepatitis C self-testing recommendation. BMJ Global Health. 8(2). e011633–e011633.
10.
Eshun‐Wilson, Ingrid, Nathan Ford, Aaloke Mody, et al.. (2023). Strengthening implementation guidelines for HIV service delivery: Considerations for future evidence generation and synthesis. PLoS Medicine. 20(3). e1004168–e1004168.
11.
Thompson, Ryan, Nathan Ford, Sheree Schwartz, et al.. (2022). Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis. PLoS Medicine. 19(3). e1003959–e1003959.
12.
Ehrenkranz, Peter, Sydney Rosen, Andrew Boulle, et al.. (2021). The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals. PLoS Medicine. 18(5). e1003651–e1003651.
13.
Zaniewski, Elizabeth, Frédérique Chammartin, Nicola Maxwell, et al.. (2020). Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa. Journal of the International AIDS Society. 23(7). e25546–e25546.
14.
Haas, Andreas D., Elizabeth Zaniewski, Nanina Anderegg, et al.. (2018). Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes. Journal of the International AIDS Society. 21(2).
15.
Ehrenkranz, Peter, Wafaa El‐Sadr, Ade Fakoya, et al.. (2018). A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders. Journal of the International AIDS Society. 21(3).
16.
Hamada, Yohhei, Nathan Ford, Karl Schenkel, & H Getahun. (2018). Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review. The International Journal of Tuberculosis and Lung Disease. 22(12). 1422–1428.
17.
Waldrop, Greer, Meg Doherty, Marco Vitória, & Nathan Ford. (2016). Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Tropical Medicine & International Health. 21(9). 1124–1130.
18.
Shubber, Zara, Edward J. Mills, Jean B. Nachega, et al.. (2016). Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Medicine. 13(11). e1002183–e1002183.
19.
Ford, Nathan & Haileyesus Getahun. (2015). Service integration to reduce HIV-associated TB mortality. Public Health Action. 5(4). 204–204.
20.
Ford, Nathan, et al.. (2006). Sustainability of long-term treatment in a rural district : the Lusikisiki model of decentralised HIV / AIDS care : HIV management. Southern African Journal of HIV Medicine. 2006(25). 17–22.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sten H. Vermund Breakdown of academic impact, for papers by Nelson K. Sewankambo Breakdown of academic impact, for papers by Anthony Harries Breakdown of academic impact, for papers by Jean B. Nachega Breakdown of academic impact, for papers by Matthew P. Fox Breakdown of academic impact, for papers by Rochelle P. Walensky Breakdown of academic impact, for papers by Jonathan Mermin Breakdown of academic impact, for papers by Marie‐Louise Newell Breakdown of academic impact, for papers by David Serwadda Breakdown of academic impact, for papers by Kevin M. De Cock